GBI is an information and professional services firm founded in China in 2002. With more than 50 professionals in Shanghai, our business is providing critical data and advice covering China's pharmaceutical, biotechnology, and healthcare industries.

Our goal is to create a transparent operating environment for our clients, and provide the insights into the competitive landscape they need in order to capitalize on the tremendous opportunities available in China. Our clients depend on the news, data, and analytics we provide to make informed decisions every day.

GBI's clients include most multinational pharmaceutical companies and a leading group of biotechnology companies, healthcare companies, investors, consultants, law firms and financial analysts.

"GBI provides me with up-to-date pharmaceutical & healthcare news when I turn on my laptop every morning. I rely on GBI to collect candidates' registration information as SOURCE is a very useful BD tool."

- Senior Manager of Strategy & Business Development, Pfizer Investment Co., Ltd

"GBI’s SOURCE is a useful tool as it provides up-to-date policy and industry announcements and analysis"

- Strategy Planning Manager, Bristol-Myers Squibb